PARP inhibitor resensitizes TKI-resistant AML to TKI.

Dellomo, AJ; Lapidus, RG; Karbowski, M; Baer, MR; Kingsbury, TJ; Rassool, FV

CANCER RESEARCH, 2021; 81 (13):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索